SCHEMBL10104381

SCHEMBL10104381

Cc1cc(NCCN(C)C)c(C)c(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 2/20 0.38
CHEK1 O14757 1/20 0.37
RPS6KB1 P23443 1/20 0.36
AKT1 P31749 1/20 0.36
AKT2 P31751 1/20 0.36
RPS6KA3 P51812 1/20 0.36
BRD4 O60885 1/20 0.35
ATAD2 Q6PL18 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NOS2 P35228 2/20 0.34
ALPL P05186 1/20 0.34
ALPI P09923 1/20 0.34
NOS1 P29475 1/20 0.34
PTGES O14684 1/20 0.34
SYK P43405 1/20 0.33
SLC2A1 P11166 1/20 0.33
UTS2R Q9UKP6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104393 0.86 NCF1 (0.37) NCF1CHEK1BRD4ATAD2NPSR1
SCHEMBL10104355 0.85 ALDH1A1 (0.38) NCF1CHEK1RPS6KB1AKT1AKT2
SCHEMBL10104505 0.78 PTPN5 (0.37) ALDH1A1MEN1KMT2A
SCHEMBL10104369 0.76 NCF1 (0.38) NCF1RPS6KB1AKT1AKT2RPS6KA3
SCHEMBL24801804 0.76 MEN1 (0.37) ALDH1A1MEN1KMT2A
SCHEMBL10104380 0.74 ACP1 (0.41) RPS6KB1AKT1NPSR1ALDH1A1MEN1
SCHEMBL10104260 0.71 RAPGEF4 (0.44) NOS2NOS1SYK
SCHEMBL10104376 0.71 TP53 (0.32) NPSR1MEN1KMT2A
SCHEMBL9023734 0.71 POLB (0.43) NCF1CHEK1BRD4ATAD2NPSR1
SCHEMBL91657 0.69 SMN1; SMN2 (0.40) ALDH1A1MEN1KMT2ASYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889665-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-18 US disclosed
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
US-20110183952-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183952-A1 NEW CHEMICAL COMPOUNDS MKI67, CCNA1, CCNT1 NCF1 344/4885CHEK1 1544/4885RPS6KB1 146/4885
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 NCF1 293/4885CHEK1 863/4885RPS6KB1 513/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 NCF1 1772/4885CHEK1 468/4885RPS6KB1 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.